Skip to content

Innoviva, Inc. INVA PP&E Sale Proceeds

PP&E Sale Proceeds at other companies

Alkermes logo
AlkermesALKS
$9K-99.5%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$19.6M

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.41B+9.7%
P/E3.5×
P/S4.2×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment.

The official record: Innoviva, Inc.’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s pp&e sale proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s PP&E sale proceeds?
Innoviva, Inc. (INVA) reported PP&E sale proceeds of $12K in Q4 2025.
How has Innoviva, Inc.'s PP&E sale proceeds changed year-over-year?
Innoviva, Inc.'s PP&E sale proceeds increased by 300.0% year-over-year, from $3K to $12K.
What does PP&E sale proceeds mean?
Cash received from selling property, plant, and equipment no longer needed for operations.